BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21393977)

  • 21. Neutrophil/eosinophil-rich type of primary cutaneous anaplastic large cell lymphoma: a clinicopathological, immunophenotypic and molecular study of nine cases.
    Kong YY; Dai B; Kong JC; Lu HF; Shi DR
    Histopathology; 2009 Aug; 55(2):189-96. PubMed ID: 19694826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary cutaneous CD30+ large T-cell lymphoma in a patient with psoriasis treated with cyclosporine.
    Corazza M; Zampino MR; Montanari A; Altieri E; Virgili A
    Dermatology; 2003; 206(4):330-3. PubMed ID: 12771475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary cutaneous CD30+ large-cell lymphoma presenting as a scrotal plaque.
    Modi S; Yang DJ; Sule N; Rosen T
    Dermatol Online J; 2009 Dec; 15(12):9. PubMed ID: 20040259
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anaplastic large-cell T-cell lymphoma.
    Stein JA; Soldano AC; Latkowski JA
    Dermatol Online J; 2008 May; 14(5):15. PubMed ID: 18627751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The black box warning for topical calcineurin inhibitors: looking outside the box.
    Fonacier L; Charlesworth EN; Spergel JM; Leung DY
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):117-20. PubMed ID: 16892793
    [No Abstract]   [Full Text] [Related]  

  • 27. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators.
    Kempf W
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():58-70. PubMed ID: 16412214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective IgM deficiency in CD30+ cutaneous lymphoproliferative disorder.
    Saini S; Dettore AJ; Bhambhani KJ; Buck S; Poulik J; Savaşan S
    J Pediatr Hematol Oncol; 2011 May; 33(4):e156-9. PubMed ID: 21516014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapy.
    Yu JB; McNiff JM; Lund MW; Wilson LD
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1542-5. PubMed ID: 18037577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders.
    Greisser J; Palmedo G; Sander C; Kutzner H; Kazakov DV; Roos M; Burg G; Kempf W
    J Cutan Pathol; 2006 Nov; 33(11):711-5. PubMed ID: 17083688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus-associated lymphoproliferative disease after long-standing cyclosporine therapy for psoriasis: a case of spontaneous regression.
    Lelièvre JD; Sacre K; Adle-Biassette H; Molinier-Frenkel V; Gaulard P; Papo T
    J Am Acad Dermatol; 2005 Feb; 52(2 Suppl 1):24-7. PubMed ID: 15692507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary cutaneous CD30-positive anaplastic large-cell lymphoma of the external auditory canal.
    Marçal N; Campelos S; Dias L; Gonçalves M; Pereira G; Godinho T
    Ear Nose Throat J; 2012 Dec; 91(12):E10-2. PubMed ID: 23288823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple nodules in a linear pattern on the leg.
    Chia J; Joseph M; Loo WJ
    Clin Exp Dermatol; 2012 Aug; 37(6):698-700. PubMed ID: 22300163
    [No Abstract]   [Full Text] [Related]  

  • 34. Multifocal primary cutaneous CD30+ anaplastic large cell lymphoma responsive to thalidomide: the molecular mechanism and the clinical application.
    Lee JH; Cheng AL; Lin CW; Kuo SH
    Br J Dermatol; 2009 Apr; 160(4):887-9. PubMed ID: 19222454
    [No Abstract]   [Full Text] [Related]  

  • 35. Neurotoxicity in the setting of pediatric atopic dermatitis treated with modified cyclosporine and itraconazole.
    Bayers SL; Arkin L; Bohaty B; Paller AS
    J Am Acad Dermatol; 2013 Oct; 69(4):e177-8. PubMed ID: 24034387
    [No Abstract]   [Full Text] [Related]  

  • 36. [Primary cutaneous anaplastic CD30+ large cell lymphoma].
    Marrero-Calvo MD; Rodríguez-Serna M; Castejón-Calvete P; Peláez-Malagón S
    Actas Dermosifiliogr; 2007 Apr; 98(3):194-7. PubMed ID: 17504705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Primary cutaneous anaplastic large cell lymphoma: clinical presentation, therapy and prognosis study of 10 cases].
    Lü Z; Shi YK; He XH; Qin Y; Zhou SY; Zhang CG; Liu P; Yang JL
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1247-50. PubMed ID: 20646596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Primary cutaneous anaplastic large-cell lymphoma.
    Perry E; Karajgikar J; Tabbara IA
    Am J Clin Oncol; 2013 Oct; 36(5):526-9. PubMed ID: 21552098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis.
    Kwakkel-van Erp JM; Haeck IM; Paantjens AW; van de Graaf EA; van Ginkel WG; Knol MJ; de Bruin-Weller MS; Lammers JW; Knol EF; Bruijnzeel-Koomen C; Otten HG
    J Am Acad Dermatol; 2010 Sep; 63(3):e70-2. PubMed ID: 20708466
    [No Abstract]   [Full Text] [Related]  

  • 40. CD30-rich transformed mycosis fungoides or anaplastic large cell lymphoma? How to get it right.
    Kadin ME
    Br J Dermatol; 2015 Jun; 172(6):1478-1479. PubMed ID: 26036155
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.